GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now emerging as a prominent focus in therapeutic studies, largely due to its impressive impact on controlling diseases such as second type diabetes and obesity. Recent research have shown that in addition to glucose control, GLP-1 agonists offer benefits for circulatory health and possi